A minor catalytic activity of Src family kinases is sufficient for maximal activation of mast cells via the high-affinity IgE receptor

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 84-93

  Poderycki, Michael ^a   Tomimori, Yoshiaki ^a,d   Ando, Tomoaki ^a   Xiao, Wenbin ^a   Maeda Yamamoto, Mari ^b   Sauer, Karsten ^c   Kawakami, Yuko ^a   Kawakami, Toshiaki ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b NATIONAL INSTITUTE OF VEGETABLE AND TEA SCIENCE   (Japan)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 6; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; ENZYME INHIBITOR; LYN PROTEIN-TYROSINE KINASE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CATALYSIS; CELL ACTIVATION; CELL STIMULATION; CYTOKINE PRODUCTION; GENE DELETION; MAST CELL; MAST CELL DEGRANULATION; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR AFFINITY; WILD TYPE; ANIMAL; DRUG EFFECT; ENZYMOLOGY; IMMUNOBLOTTING; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; ENZYME INHIBITORS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MAST CELLS; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; RECEPTORS, IGE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 73949093141     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901590     Document Type: Article

References (33)

1. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
2. Kinet, J. P. 1999. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17: 931-972.
3. Turner, H., and J. P. Kinet. 1999. Signalling through the high-affinity IgE receptor FcεRI. Nature 402(6760, Suppl): B24-B30. (Pubitemid 129517085)
4. Rivera, J., and A. M. Gilfillan. 2006. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 117: 1214-1225, quiz 1226.
5. Gilfillan, A. M., and C. Tkaczyk. 2006. Integrated signalling pathways for mastcell activation. Nat. Rev. Immunol. 6: 218-230.
6. Parravicini, V., M. Gadina, M. Kovarova, S. Odom, C. Gonzalez-Espinosa, Y. Furumoto, S. Saitoh, L. E. Samelson, J. J. O'Shea, and J. Rivera. 2002. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3: 741-748.
7. Hong, H., J. Kitaura, W. Xiao, V. Horejsi, C. Ra, C. A. Lowell, Y. Kawakami, and T. Kawakami. 2007. The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood 110: 2511-2519.
8. Kawakami, Y., J. Kitaura, A. B. Satterthwaite, R. M. Kato, K. Asai, S. E. Hartman, M. Maeda-Yamamoto, C. A. Lowell, D. J. Rawlings, O. N. Witte, et al. 2000. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J. Immunol. 165: 1210-1219.
9. 2+ mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells. J. Immunol. 158: 2350-2355.
10. Xiao, W., H. Nishimoto, H. Hong, J. Kitaura, S. Nunomura, M. Maeda-Yamamoto, Y. Kawakami, C. A. Lowell, C. Ra, and T. Kawakami. 2005. Positive and negative regulation of mast cell activation by Lyn via the FceRI. J. Immunol. 175: 6885-6892.
11. Yamashita, Y., N. Charles, Y. Furumoto, S. Odom, T. Yamashita, A. M. Gilfillan, S. Constant, M. A. Bower, J. J. Ryan, and J. Rivera. 2007. Genetic variation influences FcεRI-induced mast cell activation and allergic responses. J. Immunol. 179: 740-743.
12. Nishida, K., S. Yamasaki, Y. Ito, K. Kabu, K. Hattori, T. Tezuka, H. Nishizumi, D. Kitamura, R. Goitsuka, R. S. Geha, et al. 2005. FcεRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J. Cell Biol. 170: 115-126.
13. Kitaura, J., W. Xiao, M. Maeda-Yamamoto, Y. Kawakami, C. A. Lowell, and T. Kawakami. 2004. Early divergence of Fce receptor I signals for receptor upregulation and internalization from degranulation, cytokine production, and survival. J. Immunol. 173: 4317-4323. (Pubitemid 39280659)
14. Barouch-Bentov, R., J. Che, C. C. Lee, Y. Yang, A. Herman, Y. Jia, A. Velentza, J. Watson, L. Sternberg, S. Kim, et al. 2009. A conserved salt bridge in the G loop of multiple protein kinases is important for catalysis and for in vivo Lyn function. Mol. Cell 33: 43-52.
15. Chan, V. W., F. Meng, P. Soriano, A. L. DeFranco, and C. A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7: 69-81.
16. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301-311.
17. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3: 549-560.
18. Kitaura, J., J. Song, M. Tsai, K. Asai, M. Maeda-Yamamoto, A. Mocsai, Y. Kawakami, F. T. Liu, C. A. Lowell, B. G. Barisas, et al. 2003. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI. Proc. Natl. Acad. Sci. USA 100: 12911-12916.
19. Kawakami, Y., J. Kitaura, L. Yao, R. W. McHenry, Y. Kawakami, A. C. Newton, S. Kang, R. M. Kato, M. Leitges, D. J. Rawlings, et al. 2003. A Ras activation pathway dependent on Syk phosphorylation of protein kinase C. Proc. Natl. Acad. Sci. USA 100: 9470-9475.
20. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066. (Pubitemid 30398356)
21. Kitaura, J., T. Kinoshita, M. Matsumoto, S. Chung, Y. Kawakami, M. Leitges, D. Wu, C. A. Lowell, and T. Kawakami. 2005. IgE- and IgE+Ag-mediated mast cell migration in an autocrine/paracrine fashion. Blood 105: 3222-3229.
22. Nishimoto, H., S. W. Lee, H. Hong, K. G. Potter, M. Maeda-Yamamoto, T. Kinoshita, Y. Kawakami, R. S. Mittler, B. S. Kwon, C. F. Ware, et al. 2005. Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood 106: 4241-4248.
23. Pribluda, V. S., C. Pribluda, and H. Metzger. 1994. Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Proc. Natl. Acad. Sci. USA 91: 11246-11250.
24. Baran, C. P., S. Tridandapani, C. D. Helgason, R. K. Humphries, G. Krystal, and C. B. Marsh. 2003. The inositol 5′-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity. J. Biol. Chem. 278: 38628-38636.
25. Phee, H., A. Jacob, and K. M. Coggeshall. 2000. Enzymatic activity of the Src homology 2 domain-containing inositol phosphatase is regulated by a plasma membrane location. J. Biol. Chem. 275: 19090-19097.
26. Hernandez-Hansen, V., A. J. Smith, Z. Surviladze, A. Chigaev, T. Mazel, J. Kalesnikoff, C. A. Lowell, G. Krystal, L. A. Sklar, B. S. Wilson, et al. 2004. Dysregulated FceRI signaling and altered Fyn and SHIP activities in Lyndeficient mast cells. J. Immunol. 173: 100-112.
27. Kamps, M. P., and B. M. Sefton. 1986. Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src. Mol. Cell. Biol. 6: 751-757.
28. Yi, T. L., J. B. Bolen, and J. N. Ihle. 1991. Hematopoietic cells express two forms of lyn kinase differing by 21 amino acids in the amino terminus. Mol. Cell. Biol. 11: 2391-2398.
29. Odom, S., G. Gomez, M. Kovarova, Y. Furumoto, J. J. Ryan, H. V. Wright, C. Gonzalez-Espinosa, M. L. Hibbs, K. W. Harder, and J. Rivera. 2004. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J. Exp. Med. 199: 1491-1502.
30. Verhagen, A. M., M. E. Wallace, A. Goradia, S. A. Jones, H. A. Croom, D. Metcalf, J. E. Collinge, M. J. Maxwell, M. L. Hibbs, W. S. Alexander, et al. 2009. A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency. J. Immunol. 182: 2020-2029.
31. Huber,M., C. D. Helgason, J. E. Damen, L. Liu, R. K. Humphries, and G. Krystal. 1998. The Src homology 2-containing inositol phosphatase (SHIP) is the gate-keeper of mast cell degranulation. Proc. Natl. Acad. Sci. USA 95: 11330-11335.
32. Kitaura, J., K. Asai, M. Maeda-Yamamoto, Y. Kawakami, U. Kikkawa, and T. Kawakami. 2000. Akt-dependent cytokine production in mast cells. J. Exp. Med. 192: 729-740.
33. Gomez, G., C. Gonzalez-Espinosa, S. Odom, G. Baez, M. E. Cid, J. J. Ryan, and J. Rivera. 2005. Impaired FceRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J. Immunol. 175: 7602-7610. (Pubitemid 41713460)